Psychedelic Drugmaker Definium Surges on Depression Drug Success (opens original article in a new tab)

Psychedelic Drugmaker Definium Surges on Depression Drug Success. Definium Therapeutics Inc. shares rally as much as 60% Monday after late-stage trial data showed “groundbreaking” results in the psychedelic drug developer’s experimental treatment for major depressive disorders.

• Definium Therapeutics Inc. shares surged up to 60% on Monday
• Late-stage trial data showed
• The experimental treatment is for major depressive disorders